Phase III-study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia: AMLSG ULM study HD98B

V137

  • Schlenk, R. F.
  • Fröhling, S.
  • Benner, A.
  • Addamo, B.
  • Hartmann, F.
  • del Valle, F.
  • Pralle, H.
  • Fischer, J. T.
  • Kölbel, C. B.
  • Grimminger, W.
  • Mergenthaler, H. G.
  • Preiss, J.
  • Hensel, M.
  • Glasmacher, A.
  • Peschel, C.
  • Waterhouse, C.
  • Salwender, H.
  • Biedermann, H. G.
  • Kneba, M.
  • Kremers, S.
  • Koller, E.
  • Griesinger, F.
  • Döhner, K.
  • Haas, R.

  • H. Döhner on behalf of the AMLSG ULM

Onkologie 26:p 1, October 2003.
Copyright © 2003 S. Karger AG, Basel